Dexketoprofen and Ibuprofen in Long Bone Fractures
Comparison of Analgesic Efficacy of Dexketoprofen and Ibuprofen in Long Bone Fractures: Randomised Controlled Double-blind Study
1 other identifier
interventional
100
1 country
1
Brief Summary
The aim of this study was to compare the efficacy of ibuprofen and dexketoprofen, two common analgesic drugs used in pain control in patients with long bone fractures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4 pain
Started Sep 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2023
CompletedFirst Submitted
Initial submission to the registry
September 23, 2023
CompletedFirst Posted
Study publicly available on registry
September 29, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2024
CompletedOctober 2, 2023
September 1, 2023
1 year
September 23, 2023
September 28, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Visual analog scale
The pain is determined using a 100 mm scale. Patients are instructed to mark the level of pain they experience, with 0 mm indicating no pain and 100 mm indicating the presence of maximum pain.
120 minute
Study Arms (2)
ibuprofen
EXPERIMENTALibuprofen intravenous 800 mg
dexketoprofen
EXPERIMENTALdexketoprofen intravenous 50 mg
Interventions
Eligibility Criteria
You may qualify if:
- over 18 years
- Patients under 80 years of age
- Patients who agreed to participate in the study
- One of the tibia, femur and humerus bones is broken
- Patients with a VAS score of 50 and above
- Patients with no other injuries requiring emergency surgery
- Previously known adverse reactions to the active ingredient of the drugs to be used patients with no history
- Conscious patients
- Oriented cooperative patients
You may not qualify if:
- Patients under the age of 18 and over the age of 80
- Patients who did not agree to participate in the study
- Patients with vital signs outside the normal limits
- Patients with a history of adverse reactions to known NSAIDs
- Those who cannot determine the severity of pain on the VAS
- Patients with a VAS Score of 50 mm or less
- Those with other orthopedic injuries pregnant women
- Those with advanced systemic disease
- Those with malignancy
- Those with chronic liver and kidney disease
- Those who use neuro-psychiatric drugs with sedative and analgesic effects
- Those with a history of psychological and neurological diseases
- Patients using analgesics 8 hours before the examination
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara Bilkent Şehir Hastanesi
Ankara, 06170, Turkey (Türkiye)
Related Publications (2)
Poonai N, Bhullar G, Lin K, Papini A, Mainprize D, Howard J, Teefy J, Bale M, Langford C, Lim R, Stitt L, Rieder MJ, Ali S. Oral administration of morphine versus ibuprofen to manage postfracture pain in children: a randomized trial. CMAJ. 2014 Dec 9;186(18):1358-63. doi: 10.1503/cmaj.140907. Epub 2014 Oct 27.
PMID: 25349008RESULTFriday JH, Kanegaye JT, McCaslin I, Zheng A, Harley JR. Ibuprofen provides analgesia equivalent to acetaminophen-codeine in the treatment of acute pain in children with extremity injuries: a randomized clinical trial. Acad Emerg Med. 2009 Aug;16(8):711-6. doi: 10.1111/j.1553-2712.2009.00471.x. Epub 2009 Jul 14.
PMID: 19624576RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Safa Dönmez, MD
Ankara City Hospital Bilkent
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Department of Emergency Medicine, M.D. Specialist
Study Record Dates
First Submitted
September 23, 2023
First Posted
September 29, 2023
Study Start
September 1, 2023
Primary Completion
September 1, 2024
Study Completion
September 1, 2024
Last Updated
October 2, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share